bluebird bio (GB:0HOH)
LSE:0HOH
Holding GB:0HOH?
Track your performance easily

Bluebird Bio (0HOH) Financial Statements

0 Followers

Bluebird Bio Financial Overview

Bluebird Bio's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Bluebird Bio is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 18.57M$ 7.83M$ 12.39M$ 6.89M$ 2.38M
Gross Profit$ -7.29M$ -1.80M$ 1.44M$ 6.89M$ -995.00K
EBIT$ -64.94M$ -72.18M$ -84.73M$ -72.99M$ 21.24M
EBITDA$ -49.48M$ -46.78M$ -83.66M$ -72.02M$ 22.32M
Net Income Common Stockholders$ -69.80M$ -88.51M$ -71.73M$ -72.91M$ 21.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 212.05M$ 221.80M$ 174.29M$ 245.30M$ 318.26M
Total Assets$ 631.48M$ 619.16M$ 613.61M$ 663.39M$ 684.02M
Total Debt$ 414.34M$ 330.33M$ 303.71M$ 306.86M$ 273.38M
Net Debt$ 202.29M$ 108.53M$ 129.41M$ 61.55M$ -44.88M
Total Liabilities$ 500.44M$ 424.62M$ 391.07M$ 374.37M$ 338.00M
Stockholders Equity$ 131.05M$ 194.54M$ 222.54M$ 287.19M$ 350.00M
Cash Flow-
Free Cash Flow$ -76.45M$ -111.94M$ -63.88M$ -73.47M$ 5.23M
Operating Cash Flow$ -74.68M$ -13.79M$ -61.85M$ -72.72M$ -86.64M
Investing Cash Flow$ -655.00K$ 3.79M$ 62.08M$ 6.95M$ 82.14M
Financing Cash Flow$ 64.64M$ 66.28M$ 129.88M$ -445.00K$ 130.46M
Currency in USD

Bluebird Bio Earnings and Revenue History

Bluebird Bio Debt to Assets

Bluebird Bio Cash Flow

Bluebird Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis